BRCA Mutations and Prostate Cancer

When Angelina Jolie's double mastectomy hit the headlines in May this year there was a lot of press coverage including discussions about BRCA 1 and 2 genes. These conversations centered on women and their risk of breast or ovarian cancer. But, what about BRCA 1 and 2 in relation to prostate cancer, is there any? [...]

Worthy New Immunotherapy Clinical Trial Opens at Johns Hopkins University for Men Thinking of Surgery

The exciting thing about Provenge is not only the real survival advantage that it offers with minimal side effects, but that it is a proof of concept treatment that is heralding in the potential future of many other immunotherapies. Today, we have two new possible treatments in active phase 3 trials, Prostvac and Yervoy. [...]

Dr. Steals $35 Million Dollars and Assaults His Patients

Dr. Farid Fata, who owns Michigan Hematology Oncology which has six offices throughout Michigan in the cities of Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy and Oak Park is now out of jail, but he is on bail. Why am I even telling you about this, because as usual I have an important lesson to [...]

Additional Information on Patient Assistance Programs for Advanced Prostate Cancer

It has been brought to my attention that when I wrote the August 8, 2013 post on Pharma Sponsored Assistance Programs, I neglected to mention another excellent assistance program for men with advanced prostate cancer. The Chronic Disease Fund (CDF) has two funds that might be of specific interest to men with castrate resistant prostate [...]

Step Therapy with Zytiga & Xtandi – Two Equal Drugs Make Our Insurance Companies Our Doctors!

Recently men with advanced prostate cancer have found that their insurance companies have been dictating what drugs they can get instead of their doctor making the best decision for them. At Malecare we have seen that when a man with metastatic castrate resistant prostate cancer (mCRPC) has finished taking chemotherapy they have been steered by [...]

An Email & A Response About Prostate Cancer & Family History

I received an email from a lady from Australia that I though would be informative to share. It discusses genetic links and risk factors for hormonally related (including prostate) cancers: HER EMAIL TO ME Hi there :) I hope you don't mind me emailing you? I'm a lady from Australia and have 3 uncles with [...]

Pharma Sponsored Patient Assistance Programs from PAN for Men with Prostate Cancer

There are a number of funds available to assist men with their treatment co-pays and to help cover travel for treatments. These funds receive their financial support from the drug companies (pharama) which make voluntary contributions. Within the overarching fund there are many disease specific funds that supply co-pay and or travel support for individuals. [...]

Enzalutamide (Xtandi) Monotherapy Highly Active in Men Who Have Not Had Prior ADT

Enzalutamide (Xtandi) monotherapy induced striking declines in prostate-specific antigen (PSA) in a majority of patients with hormone-naive prostate cancer in a phase II trial, and this oral agent appears to have little effect on bone mineral density. If these findings are confirmed in a phase III trial, then enzalutamide may be an alternative to androgen [...]

Side Effects of Xofigo – Are They Significant?

The following post is actually a response to a listserve issue over the side effects of Xofigo. I decided to post my response here to avoid the limit of lines allowed on the listserve and because I feel that it is also of interest to my regular readers of this blog. My response is using [...]

Go to Top